Literature DB >> 9546795

In vivo imaging of oligonucleotides with positron emission tomography.

B Tavitian1, S Terrazzino, B Kühnast, S Marzabal, O Stettler, F Dollé, J R Deverre, A Jobert, F Hinnen, B Bendriem, C Crouzel, L Di Giamberardino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9546795     DOI： 10.1038/nm0498-467

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  32 in total

Review 1.  Imaging with radiolabeled antisense oligonucleotides for the detection of intracellular messenger RNA and cardiovascular disease.

Authors:  M K Dewanjee; N Haider; J Narula
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

2.  Characterization of a synthetic anionic vector for oligonucleotide delivery using in vivo whole body dynamic imaging.

Authors:  Bertrand Tavitian; Stéphane Marzabal; Valérie Boutet; Bertrand Kühnast; Salvatore Terrazzino; Marinette Moynier; Frédéric Dollé; Jean Robert Deverre; Alain R Thierry
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

Review 3.  Imaging gene expression: principles and assays.

Authors:  S S Gambhir; J R Barrio; H R Herschman; M E Phelps
Journal:  J Nucl Cardiol       Date:  1999 Mar-Apr       Impact factor: 5.952

4.  Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.

Authors:  A Jacobs; M Dubrovin; J Hewett; M Sena-Esteves; C W Tan; M Slack; M Sadelain; X O Breakefield; J G Tjuvajev
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

Review 5.  Positron emission tomography (PET): expanding the horizons of oncology drug development.

Authors:  Lisa A Hammond; Louis Denis; Umber Salman; Paul Jerabek; Charles R Thomas; John G Kuhn
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

Review 6.  Molecular-genetic imaging: current and future perspectives.

Authors:  Ronald G Blasberg; Juri Gelovani Tjuvajev
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 7.  Molecular imaging of cardiovascular gene products.

Authors:  Joseph C Wu; Jeffrey R Tseng; Sanjiv S Gambhir
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

8.  Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles.

Authors:  Nariman V Amirkhanov; Kaijun Zhang; Mohan R Aruva; Mathew L Thakur; Eric Wickstrom
Journal:  Bioconjug Chem       Date:  2010-04-21       Impact factor: 4.774

9.  Expanding the concept of chemically programmable antibodies to RNA aptamers: chemically programmed biotherapeutics.

Authors:  Ulrich Wuellner; Julia I Gavrilyuk; Carlos F Barbas
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-09       Impact factor: 15.336

10.  Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.

Authors:  Judy Wang; Paul Chen; Marko Mrkobrada; Meiduo Hu; Katherine A Vallis; Raymond M Reilly
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-15       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.